title: Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of California, San Diego, La Jolla, CA, USA h33kim@ucsd.edu.
authors.forename: Nick H
authors.initials: NH
authors.lastname: Kim
authors.affiliation: Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.
authors.forename: Eckhard
authors.initials: E
authors.lastname: Mayer
mesh_terms: D000800:Angioplasty, Balloon / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D062186:Arterial Pressure / Q000187:drug effects; D004691:Endarterectomy / Q000009:adverse effects; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology / Q000266:history / Q000503:physiopathology / Q000628:therapy*; D011651:Pulmonary Artery / Q000187:drug effects* / Q000503:physiopathology / Q000601:surgery*; D011655:Pulmonary Embolism / Q000150:complications / Q000175:diagnosis / Q000266:history / Q000503:physiopathology / Q000628:therapy*; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D011720:Pyrazoles; D011743:Pyrimidines; C542595:riociguat